These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26792747)

  • 1. Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells.
    Sen N; Arvin AM
    J Virol; 2016 Jan; 90(7):3284-7. PubMed ID: 26792747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
    Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
    Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
    Arvin AM
    Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Varicella-zoster virus (VZV)].
    Kanai K; Yamada S; Inoue N
    Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
    Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
    J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
    Sommer MH; Zagha E; Serrano OK; Ku CC; Zerboni L; Baiker A; Santos R; Spengler M; Lynch J; Grose C; Ruyechan W; Hay J; Arvin AM
    J Virol; 2001 Sep; 75(17):8224-39. PubMed ID: 11483768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
    Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
    Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
    J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
    Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
    Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.
    Niizuma T; Zerboni L; Sommer MH; Ito H; Hinchliffe S; Arvin AM
    J Virol; 2003 May; 77(10):6062-5. PubMed ID: 12719598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
    Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
    Front Immunol; 2020; 11():1. PubMed ID: 32038653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates.
    Soong W; Schultz JC; Patera AC; Sommer MH; Cohen JI
    J Virol; 2000 Feb; 74(4):1864-70. PubMed ID: 10644359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
    Che X; Zerboni L; Sommer MH; Arvin AM
    J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus: molecular virology and virus-host interactions.
    Arvin AM
    Curr Opin Microbiol; 2001 Aug; 4(4):442-9. PubMed ID: 11495809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of varicella zoster virus pathogenesis.
    Zerboni L; Sen N; Oliver SL; Arvin AM
    Nat Rev Microbiol; 2014 Mar; 12(3):197-210. PubMed ID: 24509782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-zoster virus infection of a human CD4-positive T-cell line.
    Zerboni L; Sommer M; Ware CF; Arvin AM
    Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.
    González-Motos V; Jürgens C; Ritter B; Kropp KA; Durán V; Larsen O; Binz A; Ouwendijk WJD; Lenac Rovis T; Jonjic S; Verjans GMGM; Sodeik B; Krey T; Bauerfeind R; Schulz TF; Kaufer BB; Kalinke U; Proudfoot AEI; Rosenkilde MM; Viejo-Borbolla A
    PLoS Pathog; 2017 May; 13(5):e1006346. PubMed ID: 28542541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.